A Niclosamide-Based Oral Antiviral Drug – A Possible Cure for COVID-19 Variants
CP-COV03, a niclosamide-based oral antiviral drug, may be combined with dexamethasone to raise efficacy 2.1 times. Experimental results have been published for the first time showing that an...